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ABSTRACT: Electrocardiographic effects produced by Ginkgo biloba extract (EGb) and by 
ginkgolides A (GA) and B (GB), and bilobalide (BB) were investigated in guinea pig heart 
mounted in Langendorff apparatus (Tyrode, 34 ± 0.1 oC, 95% O2, 5% CO2). Electrocardiographic 
parameters were evaluated in the conditions: 1) control with Tyrode and DMSO, 2) EGb (n=4), 
GA (n=5), GB (n=5) or BB (n=6), and 3) washout. The results showed that 0.1 and 1.0 mg/ml of 
EGb do not change the electrocardiographic parameters. However, 10 mg/ml of EGb increased 
the PR interval (PRi) at 21% (p<0.001). This increase was also observed for 50 mM GA (20%, 
p<0.001) and 70 mM BB (13%, p<0.001), which indicates Ca2+ channel block. However, the 
50 mM GB reduced the PRi at 11 % (p<0.001). The GA (23%, p<0.001), GB (16%, p<0.001), 
and BB (40%, p<0.001) reduced the QT interval (QTi), which suggests the activation of the 
potassium channel. However, EGb increased QTi (6%, p<0.001). The EGb (28%, p<0.05) and 
GB (13%, p<0.05) reduced the heart rate. Atrioventricular (AV) block was observed with EGb, 
GA, and BB. We can conclude that EGb and its terpenoids alter the ECG parameters inducing 
AV block, which indicates possible arrhythmogenic potential.
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RESUMO. Perfil eletrocardiográfico do coração de cobaia submetido ao extrato de Ginkgo 
biloba e seus terpenóides. Os efeitos eletrocardiográficos produzidos pelo extrato de Ginkgo 
biloba (EGb) e gingkolídeos A (GA) e B (GB), e bilobalide (BB) foram investigados em coração de 
cobaia  montado sistema de Langendorff (Tyrode, 34 ± 0.1 oC, 95% O2, 5% CO2). Os parâmetros 
do ECG foram avaliados nas condições: 1) Tyrode e DMSO, 2) EGb (n=4), GA (n=5), GB (n=5) 
ou BB (n=6) diluídos em DMSO e 3) washout. Os resultados demonstram que 0,1 e 1,0 mg/
mL de EGb não alteraram os parâmetros eletrocardiográficos. Entretanto, 10 mg/ml de EGb 
aumentaram o intervalo PR (PRi) em 21% (p<0.001). Esse aumento também foi observado 
com GA a 50µM (20%, p<0,001) e BB a 70 mM (13%, p<0,001) indicando bloqueio de canais 
de cálcio. Por outro lado, GB reduziu o PRi (11%, p<0,001). O intervalo QT (QTi) foi reduzido 
por GA (23%, p<0,001), GB (16%, p<0,001) e BB (40%, p < 0.001) sugerindo uma ativação de 
canais de potássio. Entretanto, EGb aumentou o QTi (6%, p<0.001). A frequência cardíaca foi 
reduzida por EGb (28%, p<0.05) e GB (13%, p<0.05). Bloqueios átrio-ventriculares (BAV) foram 
observados com EGb, GA e BB. Podemos concluir que EGb e os terpenos alteram parâmetros 
eletrocardiográficos induzindo BAV e demonstrando possível potencial arritmogênico.
Palavras-chave: Ginkgo biloba, ginkgolídeo A, ginkgolídeo B, bilobalide, coração.
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INTRODUCTION
Since long time the Chinese folk medicine 
uses Ginkgo biloba extracts (Chen et al, 2005). This 
plant continues to be largely employed and studied. 
The standard extract of Ginkgo biloba leaf (EGb761) 
contains 24 % of flavonoids glycosides (quercetin, 
kaempferol, isorhamnetin, etc.), 6 % terpenoids 
(3.1 % are ginkgolides A, B, C, and J and 2.9 % 
is bilobalide), and 5–10 % organic acids (Cheng, 
1996; Huh & Staba, 1992; Kressmann et al., 2002; 
Qi et al., 2004).
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Ginkgo biloba may be of great value in 
cases of age-related mental dysfunction (Kleijnen 
& Knipschild, 1992; Zhang et al., 2000; Maclennan 
et al., 2002) including senility, dementia (Le Bars 
et al., 1997), and diminished memory (Keenedy 
et al., 2000). Numerous preclinical studies have 
shown the neuroprotective effects of the standard 
extract EGb761 and support the notion that it may 
be effective in the treatment and prevention of 
neurodegenerative disorders such as Alzheimer’s 
disease2. Anti-oxidative, anti-apoptosis, anti-
inflammation, protection against mitochondrial 
dysfunction, amyloidogenesis and amyloid beta 
peptide (Aβ) aggregation, ion homeostasis, 
modulation of phosphorylation of tau protein and 
even induction of growth factors are possible 
mechanisms of action (Cheng, 1996).
Several authors reported that therapeutic 
properties presented by EGb seems to be 
associated to its vasorelaxant action involving 
activation of the cellular nitric oxide pathway, 
antagonism of the platelet activating factor (PAF), 
anti-oxidant effect (Diamond et al., 2000), and/or 
the inhibition of Ca2+ influx through the L-type Ca2+ 
channel (Satoh & Nishida, 2004). Ginkgolide B 
(GB) could antagonize PAF receptors, preventing 
thus the ischemical damage of myocardial cells 
(Keeskemeti & Balogh, 2001). Experimental 
results obtained with GB revealed that it prevented 
cardiac arrhythmias induced by the ischemia-
reperfusion protocol (Wainwright et al, 1989; Koltai 
et al., 1989).
Was  ve r i f i ed  tha t  EGb (120  mg) 
administrated during 7 days to healthy volunteers 
did not modify ECG parameters neither the heart 
rate, nor systolic or the diastolic blood pressures16. 
However, it was reported a case of a patient that 
used EGb and presented ventricular arrhythmias 
that only disappeared after discontinuing EGb 
(Cianfrocca et al., 2002). EGb and bilobalide (BB), 
used at high concentrations, usually produced 
cardiac arrhythmias and/or sinus arrest in rats 
(Satoh & Nishida, 2004). Recently, was reported 
that EGb in high concentrations reduced the 
contraction force in rat heart and decreased of 
mitochondrial respiratory function (Baliutyte et al., 
2012). However, the authors don´t elucidate what 
was the compound bioactive responsible for this 
effect. Such findings encourage us to study the 
effect of EGb and some of its majoritaria terpenoids 
(ginkgolide A, ginkgolide B and bilobalide) on the 
eletrocardiographic parameters in guinea pig 
isolated heart, which can be responsible of the 
EGb effect.
MATERIALS AND METHODS
Animals
The experiments were carried out on the 
guinea pig (Cavia porcellus) heart of male adult 
animals (300 to 500 g) of both genders. Animals 
had free access to food and water Ad libtum and 
were kept at room temperature (27 ± 3 oC) with 12 
h of light-dark cycles. The research project was 
previously approved by the Ethical Animal Research 
Committee of the Federal University of Sergipe, 
according to the protocol #33/07.
Drugs
Ginkgo biloba extract (EGb) used was a 
standardized extract obtained from leaves, containing 
25.2 % flavonoids glycosides and 3.5 % terpene 
lactones, was provided by Fármacos (Sergipe) from 
Hong Kong (China). Ginkgolides A and B, as well 
as bilobalide were purchased from Sigma-Aldrich 
(St. Louis, MO, USA). NaCl, KCl, MgCl2, NaHCO3, 
CaCl2, Glucose, NaH2PO4 were from Merck S.A. 
Indústrias Químicas (Rio de Janeiro, Brazil), dimethyl 
sulfoxide (DMSO) from Vetec Química Fina LTDA 
(Rio de Janeiro, Brazil), carbogen mixture from White 
Martins Gases Industriais S.A. (São Paulo, Brazil), 
and heparin (Liquemine) from Roche Laboratories 
(São Paulo, SP, Brazil).
Isolated heart experimental assembly
Guinea pigs were sacrificed by decapitation 
30 minutes after administration of heparin (1000 
I.U., i.p.). Their hearts were removed, mounted on 
a Langendorff apparatus of constant flow (Döring, 
1990), and perfused with Tyrode solution (mM): NaCl 
120.0, KCl 2.7, MgCl2 0.9, NaHCO3 11.9, CaCl2 1.37, 
Glucose 5.5, NaH2PO4 0.4. This solution was warmed 
up to 34 ± 0.1 oC (Haake F3, Berlin, Germany), 
oxygenated and buffered by carbogen mixture (95 
% O2 and 5 % CO2). Tyrode was thoroughly filtered 
(cellulose acetate membrane, mesh 0.45 µm) before 
using to avoid vascular microembolia (Harrison & 
Raymond, 1951). The heart, mounted into the organ 
chamber, was electrically driven by suprathreshold 
pulses of DC current, which were generated isolated 
from the ground (Anapulse Stimulator 302-T, WPI 
Instruments, Inc., 60 Fitch Street, POX 3110, New 
Haven, Connecticut 06515, USA; Digitimer D4030, 
Digitimer DS2, Digitimer Limited, Tewin Road, 
Welwyn Garden City, Hertfordshire, England). The 
electrical stimuli were delivered through a pair of 
stainless steel electrodes connected to the right 
atrium appendage. The whole preparation was 
maintained immersed in Tyrode (50 ml) in which 
three electrodes (Ag/AgCl/NaCl, 1 M) were placed 
for sensing the heart electrical signal. This allowed 
the ECG to be recorded. ECG signals were amplified 
821
Rev. Bras. Pl. Med., Campinas, v.16, n.4, p.819-825, 2014.
(HP8811B, HP7754A, HP7754B, Hewlett-Packard, 
Chicago, Illinois, USA) and stored in a computer 
for off-line processing (DI-205, DI-400, Windaq 
Pro, Dataq, 241 Springside Drive Suite 200, Akron, 
Ohio 44 333, USA). Biological preparations were 
stabilized for 30 minutes before beginning the 
experimental maneuvers. 
Electrocardiographic parameters and heart 
rate measurements 
The fol lowing electrocardiographic 
parameters were measured: PR interval (PRi), QT 
interval (QTi), and QRS complex duration (QRS). 
They were evaluated during the control situation 
(Tyrode + DMSO 0.5 %), test (EGb, GA, GB or BB 
diluted in DMSO 0.5 %), and washout (Tyrode + 
DMSO 0.5 %). The effect Ginkgo biloba constituents 
on the heart rate was studied on isolated heart 
allowed to beat spontaneously. To accomplish that, 
successive R-R intervals were determined during 
control, test, and washout (Calculate and WindaqEx 
softwares from Dataq, Akron, Ohio, USA).
Statistical analysis
Data were analyzed by using ANOVA 
one-way followed by the ‘post hoc’ test of Tukey. 
Differences were significant when p < 0.05. Results 
are presented as mean ± standard deviation.
RESULTS 
The electrocardiographic (ECG) changes 
promoted by EGb (10 mg/ml), GA (50 µM), GB 
(70 µM), and BB (70 µM) on the PR interval (PRi) 
are illustrated in Fig. 1A. PRi is measured from 
the beginning of the P wave to beginning of the 
QRS complex and represent the time conduction 
of electrical impulse through atrioventricular node 
(AV node) (Azevedo, 1999). We results revealed 
that slow concentration of EGb (0.1 and 1.0 mg/ml) 
not evoked significant alteration on the ECG profile 
(data not shown). However, 10 mg/ml EGb was able 
to alter ECG parameters increasing significantly the 
PRi at 21 ± 2.0 % (p < 0.001). Furthermore, we also 
verified that of terpenoids tested only GA (20 ± 5.0 
%, p < 0.001) and BB (13 ± 0.39 %, p<0.001) were 
able to increased this interval. On the other hand, the 
opposite was observed for GB that slightly decreased 
PRi at 6.0 ± 0.39 % (p < 0.001). It was found PRi 
changes promoted by EGb and GB were not restored 
to the control situation after the washing procedure. 
Beyond evaluate PRi also we determined 
QT interval (QTi) in heart perfused by both EGb 
or terpenoids. The QTi is a measure of the time 
between the start of the Q wave and the end of the 
T wave in the heart’s electrical cycle and represents 
electrical depolarization and repolarization of the left 
and right ventricles22. Ours results showed that the 
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FIGURE 1. Effects of Ginkgo biloba extract (EGb, 10 mg/ml, n = 4) and its constituents GA (50 mM, n = 5), GB 
(70 mM, n = 5), and BB (70 mM, n = 6) on the PRi (panel A) and QTi (panel B) of guinea pig isolated heart (34 
± 0.1 oC, stimuli: 40 V, 1 ms, *p < 0.001).
A
B
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three terpenoids tested GA, GB, and BB reduced the 
QTi from 209 ± 0.19 ms to 161 ± 2.3 ms (23 %, n = 5, 
p < 0.001), 216 ± 0.3 ms to 181 ± 4.0 ms (16 %, n = 
6, p < 0.001), and from 218 ± 0.14 ms to 130 ± 0.73 
ms (40 %, n = 6, p < 0.001), respectively. Moreover, 
unlike behavior was observed by EGb increasing QTi 
from 211 ± 0.11 ms to 223 ± 0.9 ms (6.0 %, n = 4, p 
< 0.001). These effects disappeared after removing 
Gingko biloba constituents from the perfusion fluid 
(Fig. 1B). QRS complex duration was not altered by 
EGb or by the terpenoids tested. 
Fig. 2A show ECG traces of spontaneous 
beating heart in control situation (top trace), with 
EGb (middle trace) and after washout (bottom trace). 
This results show that EGb induced increased of 
RR interval from 386 ms to 500 ms (29 %). This 
effect was partially reversible after 20 minutes of 
washout (426 ms). Fig. 2B summarizes the heart 
rate decrease promoted by both EGb and GB from 
147 ± 15 bpm to 106 ± 22 bpm (28 %, n=4, p<0.05) 
and from 158 ± 18 bpm to 138 ± 21 bpm (13%, n=5, 
p<0.05), respectively. This bradycardia disappeared 
20 minutes after initiating the washout. Neither GA 
nor BB modified the heart rate. 
In  iso la ted hear t  a l lowed to  beat 
spontaneously, EGb (10 mg/ml) did not induce 
arrhythmia, but in preparations electrically driven, 
it prolonged the PRi leading to a Wenkebach 
second degree AV block as seen in Fig. 3A. The 
tracing shows the PRi increasing progressively 
before appearing a complete AV block. This type 
of arrhythmia was observed in 40 % of hearts 
prefunded with EGb. GA (50 mM) on spontaneously 
beating heart induced the appearance of ventricular 
extrassystole (Panel B) and also was elicited third 
degree AVB with a multifocal ventricular rhythm 
(Panel C). BB evoked a third degree AVB as can be 
seen in panel D and Wenkebach periods (data not 
shown). The arrhythmias produced by EGb, GA, and 
BB disappeared during washout. 
DISCUSSION
Pervious study evidenced that high 
concentration of Ginkgo biloba extract was able 
to elicit electrocardiographic changes in rat heart 
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FIGURE 2. Effects of EGb and its terpenoids on the guinea pig heart rate. Panel A shows ECG registers 
of the heart beating spontaneously in control (top trace), EGb (middle trace) and washout (bottom trace). 
Panel B represents the summary of the effects of EGb, GA, GB, and BB on the guinea pig rate (n = 5, *p < 
0.001, 34 ± 0.1 oC). 
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(Baliutyte et al., 2012). However, no correlation was 
provided between extract effect and its constituents. 
It is known that the main biological effects of the 
extract of G. biloba are produced by the terpenoids 
present in its constitution. Furthermore, as EGb is a 
mixture of its constituents, the final pharmacological 
response of EGb would be result of complex 
interaction between the constituents probably by 
synergism action. Thus, we decided to compare the 
electrocardiographic effects of the extract with those 
presented by their major constituents on guinea pig 
isolated heart. 
 One of the parameters of ECG measured 
was PR interval. This interval is the time (in seconds) 
from the beginning of the P wave (onset of atrial 
excitation) to the beginning of the QRS complex 
(onset of ventricular excitation). Is important to 
emphasize that PRi evaluate principally the electrical 
conduction through the atrioventricular (AV) node. 
We results showed that EGb induced PRi interval. 
This findings corroborating with other studies 
(Baliutyte et al., 2012), that observed PRi increased 
induced by this extract. Furthermore, both GA and 
GB also induced PRi increased suggesting that both 
GA and BB can be responsible by enhance PRi 
induced by GBE. The increased PRi, also know as 
AV block of first degree, produced by EGb, GA, and 
BB showed that such compounds have a potential 
arrhythmogenic effect. This phenomenon occurs 
because they depressed the electrical conduction 
through the AV node. It´s well established that 
activity of calcium channels in AV nodal cells plays 
an important role for electrical impulse conduction 
(Conde-Garcia, 2002). The magnitude of the 
increase of L-type calcium current (ICa,L) determines 
the velocity of depolarization during the upstroke 
of an action potential in nodal cells, and thus the 
conduction velocity by AV nodal (Schram, 2002). 
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FIGURE 3. Cardiac arrhythmias induced by EGb and its constituents in guinea pig isolated heart. Panel A: EGb 
(10 mg/ml) elicited Wenkebach periods characterized by PRi increased following atrioventricular block (AVB). 
The values in milliseconds relate the measurements of PRi. Third degree AVB with multifocal ventricular rhythm 
(Panel B) and isolated ventricular extrassystole (Panel C) induced by GA (50 mM) in spontaneously beating (on) 
guinea pig heart. Panel D: third degree AVB induced by BB (70 mM) on guinea pig isolated heart. S: stimulus 
artifact; P: p wave; Q: q wave (34 ± 0.1 oC). 
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Indeed, blockers of ICa,L can reduce the amplitude of 
the nodal cell action potential and promote negative 
dromotropic effect (decrease conduction velocity) 
inducing AV block. 
Several authors showed that EGb (1 mg/
ml) markedly inhibited the ICa,L in guinea pig and rat 
ventricular myocytes submitted to a voltage-clamp 
experiments (Satoh, 2003; Satoh & Nishida, 2004). 
The reduction of ICa,L can be responsible for the AV 
block of first degree induced by EGb observed in our 
experiments. On the other hand, it´s was verified GA 
(Satoh & Nishida, 2004), GB (0.1-3 mM), and BB (1 
mM) (Satoh, 2003; Satoh & Nishida, 2004) enhanced 
the ICa,L and the delayed rectifier K+ current (IK). In 
cardiac muscle, it was evidenced that intracellular 
calcium increase can promote cellular decoupling 
by diminish the conductance of nexi (Burt & Spray, 
1988). The ability of terpenoids to block calcium 
channels has been extensively studied in recent 
years (Magyar, 2004; Cerqueira et al., 2011).
Several authors use extracts plant at high 
concentration for studies in vitro and in vivo (Circosta 
et al., 2005; Menezes et al., 2007). This fact can be 
justified due the slow percentage of majoritarian 
compounds present in this extracts. Even at low 
concentrations, these constituents are extensively 
studied and present various biological effect (Singh 
et al., 2010). It´s was observed that changes in 
environmental conditions and other factors can 
influence in plant metabolism inducing difference 
in the levels of this majoritarian compound (Satoh, 
2005). Was used 1 mg/ml of Ginkgo biloba extract in 
isolated ventricular cardiomyocyte submitted to patch-
clamp technique (Satoh & Nishida, 2004) and in the 
present study we used 0.1, 1.0 and 10 mg/ml because 
the experiments  was carried out in isolated organ. 
In the present study, 10 mg/ml, this extract contains 
only approximately 3.5% of terpenoids of which are 
1.8 % of ginkgolides and 1.69% of bilobalide. In recent 
study, authors use several concentration of Ginkgo 
biloba, but not show the concentration of extract in 
grams (mass unity), difficultly the comparison with our 
research (Baliutyte et al., 2012).
As noted in our experiments, the QTi was 
only increased by EGb. This result reflects an increase 
in the action potential duration (APD) probably by 
potassium channel block. In fact, it was demonstrated 
in guinea pig and in rat ventricular myocytes that EGb 
(1 mg/ml) prolonged the APD (Satoh, 2004; Satoh 
& Nishida, 2004). Simultaneously, these authors 
showed that EGb markedly inhibits delay rectifying K+ 
current (IK) and also the inward rectifying K+ current (IK1) 
what could explain the prolonged QTi observed in our 
results. Unlike of extract, GA, GB, and BB decreased 
the QTi. This could be reflecting a shortening of the 
APD. Satoh & Nishida (2004) demonstrated in the 
guinea pig ventricular cardiomyocytes that GB (1 mM) 
and BB (3 mM) were able to shorten the APD and also 
increased IK. We have observed that those terpenoids 
shorten QTi that could be due to increase of IK. 
In spite of the GA decrease the QTi, 
studies performed on the guinea pig ventricular 
cardiomyocytes showed that GA (1-3 mM) prolonged 
the APD, a fact that should increase the QTi in the 
ECG (Satoh & Nishida, 2004). This finding indicates 
that the prolonging QTi by EGb can’t be attributable 
to the isolated action of a single terpenoid but to a 
synergistic action of its constituents which individually 
have an effect opposite to that shown by the extract. 
We results showed that both EGb and GB 
were able to reduce pacemaker activity of the sinus 
node. It´s was demonstrated that EGb and BB can 
changes the pacemaking activity (Satoh, 2005). 
This author reported that EGb (0.03 mg/ml) and BB 
(0.3 mM) promote a negative chronotropic effect. 
Furthermore, EGb (0.03 mg/ml) decreased the slope 
of slow diastolic depolarization (SDD) (action potential 
phase 4) of sinus nodal cells and depressed their 
spontaneous activity in a concentration-dependent 
fashion. Moreover, at high concentration, EGb and BB 
often cause dysrhythmias and/or a sinus arrest (Satoh 
& Nishida, 2004). In sino-atrial nodal cells, submitted 
to patch-clamp techniques, it´s was demonstrated 
that the following currents were decreased by EGb 
(0.03 mg/ml) and BB (0.3 mM): a) ICa,L; b) If, funny 
current (hyperpolarization-activated inward current); 
and c) IK. These results indicated that both EGb and 
BB can alter the cardiac ionic channel functioning in 
rat sino-atrial nodal cells (Satoh & Nishida, 2004).
Our findings showed that in guinea pig 
isolated heart EGb, GA and BB depress the 
conduction through atrioventricular node, leading to 
a several degrees of AVB (1st, 2nd, 3rd degrees). 
Ours results indicate that these compounds would 
can have potential arrythmogenic confirming the 
clinical findings observed in patients making use of 
extracts of Ginkgo biloba. In addition, Ginkgo biloba 
effects on mammalian myocardium are due synergic 
actions of its major constituents. 
ACKNOWLEDGMENTS
The authors wish to thanks to the Federal 
University of Sergipe, FAPITEC (Edital Universal 
07/2008), ELETROBRAS (Centrais Elétricas 
Brasileiras, Process #23113.009351/03-67), and 
CNPq (Process #478581/2008-4) for financial 
support. 
REFERENCES
Chen, B.; Caia, J.; Song, L.S.; Wang, X.; Chen, Z. Effects of 
Ginkgo biloba extract on cation currents in rat ventricular 
myocytes. Life Sciences, v.76, p.1111–1121, 2005.
Cheng, X. Progress of pharmacological reserch on 
cardiovascular and cerebral vascular effect of Ginkgo 
biloba extract and its enlightenmet. Chinese journal of
integrated traditional and Western medicine, v.16, 
825
Rev. Bras. Pl. Med., Campinas, v.16, n.4, p.819-825, 2014.
p.387-389, 1996.
Huh, H.; Staba, E.J. The botany and chemistry of Ginkgo 
biloba L. Journal of Herbs, Spices & Medicinal Plants, 
v.1, p.92–124, 1992.
Kressmann, S.; Muller, W.E.; Blume, H.H. Pharmaceutical 
quality of different Ginkgo biloba brands. Journal of 
Pharmacy and Pharmacology, v.54, p.661–669, 2002.
QI, X-Y.; ZHANG, Z-X.; XU, Y-Q. Effects of Ginkgolide B 
on action potential and calcium, potassium current in 
guinea pig ventricular myocytes. Acta Pharmacologica 
Sinica, v.25, p.203-207, 2004. 
Kleijnen, J.; Knipschild, P. Ginkgo biloba for cerebral 
insufficiency. British Journal of Clinical Pharmacology, 
v.34, p.352–358, 1992.
Zhang, W.R.; Hayashi, T.; Kitagawa, H.; Sasaki, C.; Sakai, 
K.; Warita, H.; Wang JM, Shiro Y, Uchida M, Abe K. 
Protective effect of Ginkgo biloba extract on rat brain with 
transient middle cerebral artery occlusion. Neurological 
Research, v.22, p.517–521, 2000.
Maclennan, K.M.; Darlington, C.L.; Smith, P.F. The CNS 
effects of Ginkgo biloba extracts and ginkgolide B. 
Progress in Neurobiology, v.67, p.235–257, 2002.
Le Bars, P.L.; Katz, M.M.; Berman, N.; Itil, T.M.; 
Freedman, A.M.; Schatzberg, A.F. A placebo-controlled, 
double-blind, randomized trial of an extract of Ginkgo 
biloba for dementia. The journal of the American 
Medical Association, v.278, p.1327–1332, 1997.
Keenedy, D.O.; Scholey, A.B.; Wesnes, K.A. The dose-
dependent cognitive effects of acute administration 
of Ginkgo biloba to healthy young volunteers. 
Psychopharmacology, v.151, p.416-423, 2000.
Diamond, B.J.; Shiflett, S.C.; Schoenberger, N.E. Ginkgo 
biloba extract: mechanisms and clinical indications. 
Archives of physical medicine and rehabilitation, 
v.81, p.668–678, 2000.
Satoh, H.; Nishida, S. Electropharmacological actions of 
Ginkgo biloba extract on vascular smooth and heart 
muscles. Clinica Chimica Acta, v.342, p.13-22, 2004.
Keeskemeti, V.; Balogh, I. Cardiac ultrastructural effect 
of the platelet-activating factor and its antagonist BN 
52021. Experimental and Toxicology Pathology, 
v.47, p.463-470, 2001.
Wainwright, C.L.; Parratt, J.R.; Bigaud, M. The effect of 
PAF antagonists on arrhythmias and platelets during 
acute myocardial ischemia and reperfusion. European 
Heart Journal, v.10, p.253-243, 1989. 
Koltai, M.; Tosaki, A.; Hosford, D.; Barquet, P. Ginkgolide 
B protects isolated hearts against arrhythmias induced 
by ischemia but not reperfusion. European Journal of 
Pharmacology, v.164, p.293-302, 1989. 
Kalus, J.S.; Piotrowski, A.A.; Fortier, C.R.; Liu, X.; Kluger, 
J.; White, C.M. Hemodynamic and electrocardiographic 
effects of short-term Ginkgo biloba. The Annals of 
Pharmacotherapy, v.37, p.345-349, 2003.
Cianfrocca, C.; Pelliccia, F.; Auriti, A.; Santini, M. Ginkgo 
biloba induced frequent ventricular arrhythmia. Italian 
Heart Journal, v.3, p.689-691, 2002.
Baliutyte, G.; Baniene, R.; Gendviliene, V.; Martisiene, I.; 
Trumbeckaite, S.; Borutaite, V.; Toleikis, A. Influence of 
ethanol extract of Ginkgo biloba leaves on the isolated 
rat heart work and mitochondria functions. Journal of 
Cardiovascular Pharmacology, v.59, p.450-457, 
2012.
Döring, H.J. The isolated perfused heart according 
to Langendorff technique - Function - Application. 
Physiologia Bohemoslovaca, v.39, p.481-505, 1990.
Harrison, G.E.; Raymond, W.H.A. Preparation of clean 
chemical solutions. British Medical Journal, v.2, 
p.930-932, 1951.
Azevedo, D.F. Iniciação a eletrocardiografia. Ed. 
ArtMed, 1999.
Conde-Garcia, E.A. Biofísica. Ed. Savier, Rio de Janeiro, 
2002.
Schram, G.; Pourrier, M.; Melnyk, P.; Nattel, S. 
Differential distribution of cardiac ion channels as a 
basis for regional specialization in electrical function. 
Circulation Research, v.90, p.939-950, 2002.
Satoh, H. Effects of Ginkgo biloba extract and Bilobalide, 
a main constituent, on the ionic currents in guinea 
pig ventricular cardiomyocytes. Progress in drug 
research, v.53, p.407-413, 2003.
Burt, J.M.; Spray, D.C. Inotropic agents modulate gap 
junctional conductance between cardiac myocytes. 
American Journal Physiology, v.254, p.1206-1210, 
1988.
Magyar, J.; Szentandrassy, N.; Banyaz, T.; Fulop, 
L.; Varro, A.; Nanasi, P.P. Effects of terpenoid 
derivatives on calcium current in canine and human 
ventricular cardiomyocytes. European Journal of 
Pharmacology,v.487, p.29-36, 2004.
Cerqueira, S.V.S.; Gondim, A.N.S.; Romam-campos, D.; 
Cruz, J.S.; Passos, A.G.S.; Lauton-santos, S.; Lara, 
A.; Guatimosim, S.; Conde-Garcia, E.A.; Oliveira, 
E.D.; Vasconcelos, C.M.L. R-(+)-pulegone impairs 
Ca2+ homeostasis and causes negative inotropism 
in mammalian myocardium. European Journal of 
Pharmacology, v.672, p.135-142, 2011.
Circosta, C.; De Pasquale, R.; Occhiuto, F. Cardiovascular 
effects of the aqueous extract of Gynostemma 
pentaphyllum Makino. Phytomedicine, v.2, p.638–664, 
2005.
Menezes, I.A.C.; Moreira, I.J.A.; Carvalho, A.A.; 
Antoniolli, A.R.; Santos, M.R.V. Cardiovascular effects 
of the aqueous extract from Caesalpinia ferrea: 
Involvement of ATP-sensitive potassium channels. 
Vascular Pharmacology, v.47, p.41–47, 2007.
Singh, R.D.; Gopichand, Meena, R.L.; Sharma, B.; 
Singh, B.; Kaul, V.K.; Ahuja, P.S. Seasonal variation 
of bioactive components in Valeriana jatamansi from 
Himachal Pradesh, India. Industrial Crops and 
Products, v.32, p.292–296, 2010.
Satoh, H. Comparative electropharmacological actions 
of some constituents from Ginkgo biloba extract in 
guinea-pig ventricular cardiomyocytes. Evidence 
Based  Complementary and Alternative Medicine, 
v.1, p.277-284, 2004.
Satoh, H. Suppression of pacemaker activity by Ginkgo 
biloba extract and its main constituent, bilobalide in rat 
sino-atrial nodal cells. Life Sciences, v.78, p.67–73, 
2005.
